001). Sixteen patients died (12 in the pharmacotherapy–EBL group and 4 in the early-TIPS group, P=0.01). The 1-year actuarial survival was 61% in the pharmacotherapy–EBL group versus 86% in the early-TIPS group (P<0.001). Seven patients in the pharmacotherapy–EBL group received TIPS as rescue therapy, but four died. The number of days in the intensive care unit and the percentage of time in the hospital during follow-up were significantly higher in the pharmacotherapy–EBL group than in the early-TIPS

group. No significant differences were observed between the two treatment groups with respect to serious adverse events. Conclusions:In these patients with cirrhosis who were hospitalized for acute variceal bleeding and at high risk for treatment failure, the early use of TIPS was associated with significant reductions in treatment failure and in mortality. (Current Controlled

Trials number, LDE225 datasheet ISRCTN58150114.) This study by García-Pagán et al.1 is the first randomized study comparing the use of early transjugular intrahepatic portosystemic shunt (TIPS) treatment with the current standard treatment in patients with liver cirrhosis and acute esophageal variceal bleeding. Only patients with an advanced risk of bleeding-related mortality (Child-Pugh class C and B patients with active bleeding on endoscopy)2, 3 were included. The study showed that the Proteasome inhibitor early use of TIPS (within 3 days of admission) reduced the 6-week mortality rate to 3% (33% with medical treatment) and the 1-year mortality rate to 14% (39% with medical treatment). When TIPS was used as a rescue treatment after the failure of medical treatment, the mortality rate was high (four of seven patients in the study by García-Pagán et al.), and this was comparable to previous results.4 Other (expected) beneficial effects of early TIPS placement included reduced rates of ascites, hepatorenal syndrome, MCE公司 and spontaneous bacterial peritonitis

and significantly fewer days in the intensive care unit and in the hospital (P < 0.014). This study might influence the current treatment strategy for variceal bleeding in patients with cirrhosis and lead to the stratification of these patients into groups with a high or low risk of bleeding-related mortality. As outlined in Fig. 1, patients with a high rate of bleeding-related mortality [Child-Pugh class C patients (score < 13) and Child-Pugh class B patients with active bleeding on endoscopy] may receive early TIPS treatment. They may then be followed with duplex sonography to confirm shunt patency. In contrast, as stated by the researchers, early TIPS should not be used for Child-Pugh class A patients because they have low rates of medical treatment failure and mortality. Such patients may be treated according to current recommendations with a step-up strategy using β-blocking agents, endoscopic band ligation, and rescue TIPS.